News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Biologics Making Steady Inroads Into Device Landscape, Says MedCap Advisors CEO Christopher Velis


9/26/2012 8:59:13 AM

CAMBRIDGE, Mass.--(BUSINESS WIRE)--MedCap Advisors, the mergers & acquisition and strategic consulting firm specializing in medical technology, today issued a discussion paper focused on the market penetration of biologics. The paper, “Biologics Revolution: Breaking down barriers to entry for advanced biologic solutions,” captures MedCap CEO Christopher Velis’ insights from the field.

Read at BioSpace.com


comments powered by Disqus
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES